We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
-19.86%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$179M
AUM Growth
-$913M
Cap. Flow
-$590M
Cap. Flow %
-328.64%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CHPT icon
ChargePoint
CHPT
+$468M
2
ONTF
ON24
ONTF
+$101M
3
TVRD
Tvardi Therapeutics
TVRD
+$20.9M

Sector Composition

Rank Sector Weight
1 Healthcare 48.63%
2 Consumer Discretionary 45.17%
3 Communication Services 6.21%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHPT icon
1
ChargePoint
CHPT
$133M
$81M 45.17%
202,663
-1,004,454
-83% -$468M
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$79.2M 44.14%
3,766,666
– –
LVO icon
3
LiveOne
LVO
$66M
$11.1M 6.21%
372,414
– –
MRSN
4
DELISTED
Mersana Therapeutics
MRSN
$7.51M 4.19%
31,858
– –
SENS icon
5
Senseonics Holdings Inc
SENS
$254M
$541K 0.3%
7,980
– –
ONTF
6
DELISTED
ON24
ONTF
– –
-3,637,894
Closed -$101M
TVRD
7
Tvardi Therapeutics
TVRD
$23.5M
– –
-41,641
Closed -$20.9M

Similar funds

LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

Rho Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Rho Capital Partners held 7 positions worth $179M, down 84% from $1.09B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Rho Capital Partners withdrew a net $590M in Q3 2021, closing 2 positions and reducing 1 holding. Its most notable exit was ON24, an estimated $101M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 9.8% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Rho Capital Partners's biggest Q3 2021 reduction was ChargePoint, cutting an estimated $468M.
  • Rho Capital Partners fully exited ON24 in Q3 2021, selling an estimated $101M.
  • Rho Capital Partners's ten largest holdings make up 100% of its $179M portfolio in Q3 2021.
  • Rho Capital Partners opened 0 new positions and closed 2 in Q3 2021.
  • Rho Capital Partners's portfolio value fell 84% quarter-over-quarter to $179M.

Based on Rho Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.